Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.34
(1.86%)
EUR 45.34
(1.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 498.99 Million EUR | -25.9% |
| 2022 | 673.4 Million EUR | -30.53% |
| 2021 | 969.3 Million EUR | -16.75% |
| 2020 | 1.16 Billion EUR | -2.97% |
| 2019 | 1.2 Billion EUR | -39.46% |
| 2018 | 1.98 Billion EUR | 54.84% |
| 2017 | 1.28 Billion EUR | 8.3% |
| 2016 | 1.18 Billion EUR | 25.58% |
| 2015 | 941.18 Million EUR | 9.52% |
| 2014 | 859.36 Million EUR | 6.92% |
| 2013 | 803.76 Million EUR | -10.43% |
| 2012 | 897.39 Million EUR | 8.58% |
| 2011 | 826.44 Million EUR | 12.33% |
| 2010 | 735.74 Million EUR | 18.29% |
| 2009 | 621.97 Million EUR | 5.9% |
| 2008 | 587.31 Million EUR | 19.41% |
| 2007 | 491.85 Million EUR | 20.94% |
| 2006 | 406.68 Million EUR | 5.87% |
| 2005 | 384.12 Million EUR | 29.53% |
| 2004 | 296.54 Million EUR | 12.77% |
| 2003 | 262.96 Million EUR | -4.78% |
| 2002 | 276.16 Million EUR | 287.84% |
| 2001 | 71.2 Million EUR | -68.47% |
| 2000 | 225.8 Million EUR | 191.42% |
| 1999 | -247 Million EUR | -1616.66% |
| 1998 | 16.28 Million EUR | -80.14% |
| 1997 | 81.99 Million EUR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 70.95 Million EUR | -62.24% |
| 2024 Q3 | 213 Million EUR | 13.92% |
| 2024 Q2 | 187 Million EUR | 163.53% |
| 2023 Q4 | 187.92 Million EUR | 122.79% |
| 2023 Q2 | 140 Million EUR | 4.59% |
| 2023 Q3 | 84.35 Million EUR | -39.75% |
| 2023 Q1 | 133.85 Million EUR | -31.0% |
| 2023 FY | 498.99 Million EUR | -25.9% |
| 2022 Q1 | 211.8 Million EUR | -7.51% |
| 2022 FY | 673.4 Million EUR | -30.53% |
| 2022 Q2 | 206 Million EUR | -2.74% |
| 2022 Q4 | 194 Million EUR | -15.69% |
| 2022 Q3 | 230.1 Million EUR | 11.7% |
| 2021 Q1 | 248.94 Million EUR | 40.65% |
| 2021 Q2 | 218.57 Million EUR | -12.2% |
| 2021 Q3 | 273.04 Million EUR | 24.92% |
| 2021 Q4 | 229 Million EUR | -16.13% |
| 2021 FY | 969.3 Million EUR | -16.75% |
| 2020 Q4 | 177 Million EUR | -49.93% |
| 2020 Q1 | 282.71 Million EUR | -17.57% |
| 2020 Q2 | 351 Million EUR | 24.15% |
| 2020 Q3 | 353.5 Million EUR | 0.71% |
| 2020 FY | 1.16 Billion EUR | -2.97% |
| 2019 Q2 | 253.78 Million EUR | -6.27% |
| 2019 Q4 | 343 Million EUR | 3.13% |
| 2019 Q3 | 332.58 Million EUR | 31.05% |
| 2019 FY | 1.2 Billion EUR | -39.46% |
| 2019 Q1 | 270.74 Million EUR | -36.29% |
| 2018 Q3 | 284.61 Million EUR | -71.37% |
| 2018 Q2 | 993.98 Million EUR | 256.27% |
| 2018 Q1 | 279 Million EUR | -29.19% |
| 2018 Q4 | 425 Million EUR | 49.33% |
| 2018 FY | 1.98 Billion EUR | 54.84% |
| 2017 Q3 | 309.27 Million EUR | 15.11% |
| 2017 FY | 1.28 Billion EUR | 8.3% |
| 2017 Q4 | 394 Million EUR | 27.39% |
| 2017 Q2 | 268.68 Million EUR | -12.81% |
| 2017 Q1 | 308.17 Million EUR | -16.47% |
| 2016 Q1 | 201.19 Million EUR | -30.61% |
| 2016 Q4 | 368.92 Million EUR | 24.23% |
| 2016 Q3 | 296.98 Million EUR | 12.38% |
| 2016 Q2 | 264.26 Million EUR | 31.35% |
| 2016 FY | 1.18 Billion EUR | 25.58% |
| 2015 Q3 | 233.13 Million EUR | 8.6% |
| 2015 FY | 941.18 Million EUR | 9.52% |
| 2015 Q2 | 214.66 Million EUR | 10.94% |
| 2015 Q1 | 193.5 Million EUR | -29.76% |
| 2015 Q4 | 289.94 Million EUR | 24.37% |
| 2014 Q1 | 149.39 Million EUR | -37.7% |
| 2014 Q4 | 275.49 Million EUR | 29.07% |
| 2014 FY | 859.36 Million EUR | 6.92% |
| 2014 Q2 | 171.25 Million EUR | 14.64% |
| 2014 Q3 | 213.44 Million EUR | 24.64% |
| 2013 Q2 | 201.78 Million EUR | 14.59% |
| 2013 Q1 | 176.08 Million EUR | 1.59% |
| 2013 FY | 803.76 Million EUR | -10.43% |
| 2013 Q4 | 239.8 Million EUR | 18.55% |
| 2013 Q3 | 202.29 Million EUR | 0.25% |
| 2012 Q4 | 173.33 Million EUR | -17.53% |
| 2012 FY | 897.39 Million EUR | 8.58% |
| 2012 Q1 | 277.73 Million EUR | 4.28% |
| 2012 Q2 | 228.54 Million EUR | -17.71% |
| 2012 Q3 | 210.17 Million EUR | -8.04% |
| 2011 FY | 826.44 Million EUR | 12.33% |
| 2011 Q4 | 266.34 Million EUR | 29.54% |
| 2011 Q3 | 205.6 Million EUR | 14.15% |
| 2011 Q2 | 180.12 Million EUR | 15.23% |
| 2011 Q1 | 156.31 Million EUR | -27.91% |
| 2010 Q3 | 181.82 Million EUR | -10.76% |
| 2010 Q1 | 157.25 Million EUR | -13.52% |
| 2010 Q2 | 203.74 Million EUR | 29.56% |
| 2010 FY | 735.74 Million EUR | 18.29% |
| 2010 Q4 | 216.83 Million EUR | 19.26% |
| 2009 Q2 | 157.6 Million EUR | 5.54% |
| 2009 Q3 | 153.85 Million EUR | -2.38% |
| 2009 Q4 | 181.83 Million EUR | 18.19% |
| 2009 FY | 621.97 Million EUR | 5.9% |
| 2009 Q1 | 149.32 Million EUR | -6.33% |
| 2008 Q2 | 134.13 Million EUR | 13.97% |
| 2008 FY | 587.31 Million EUR | 19.41% |
| 2008 Q4 | 159.42 Million EUR | 8.93% |
| 2008 Q3 | 146.34 Million EUR | 9.1% |
| 2008 Q1 | 117.69 Million EUR | -7.81% |
| 2007 Q3 | 126.66 Million EUR | -4.04% |
| 2007 Q2 | 132 Million EUR | 10.02% |
| 2007 FY | 491.85 Million EUR | 20.94% |
| 2007 Q1 | 119.97 Million EUR | 15.87% |
| 2007 Q4 | 127.65 Million EUR | 0.78% |
| 2006 Q2 | 101.34 Million EUR | 5.86% |
| 2006 Q4 | 103.54 Million EUR | -5.59% |
| 2006 FY | 406.68 Million EUR | 5.87% |
| 2006 Q3 | 109.67 Million EUR | 8.22% |
| 2006 Q1 | 95.73 Million EUR | -6.14% |
| 2005 FY | 384.12 Million EUR | 29.53% |
| 2005 Q4 | 101.99 Million EUR | 5.84% |
| 2005 Q3 | 96.37 Million EUR | 0.59% |
| 2005 Q2 | 95.81 Million EUR | 15.57% |
| 2005 Q1 | 82.9 Million EUR | 37.56% |
| 2004 FY | 296.54 Million EUR | 12.77% |
| 2004 Q4 | 60.27 Million EUR | -26.62% |
| 2004 Q2 | 82.44 Million EUR | 11.49% |
| 2004 Q3 | 82.13 Million EUR | -0.38% |
| 2004 Q1 | 73.94 Million EUR | 23.39% |
| 2003 Q2 | 68.96 Million EUR | 7.63% |
| 2003 Q1 | 64.07 Million EUR | -3.1% |
| 2003 FY | 262.96 Million EUR | -4.78% |
| 2003 Q4 | 59.93 Million EUR | -19.99% |
| 2003 Q3 | 74.9 Million EUR | 8.62% |
| 2002 Q2 | 74.74 Million EUR | 2.7% |
| 2002 Q3 | 70.6 Million EUR | -5.53% |
| 2002 Q4 | 66.12 Million EUR | -6.34% |
| 2002 FY | 276.16 Million EUR | 287.84% |
| 2002 Q1 | 72.77 Million EUR | 157.58% |
| 2001 FY | 71.2 Million EUR | -68.47% |
| 2001 Q4 | -126.39 Million EUR | -280.22% |
| 2001 Q3 | 70.13 Million EUR | -3.26% |
| 2001 Q2 | 72.49 Million EUR | 16.51% |
| 2001 Q1 | 62.22 Million EUR | 19.85% |
| 2000 FY | 225.8 Million EUR | 191.42% |
| 2000 Q4 | 51.91 Million EUR | -21.57% |
| 2000 Q3 | 66.19 Million EUR | 27.0% |
| 2000 Q2 | 52.12 Million EUR | 9.86% |
| 2000 Q1 | 47.44 Million EUR | 165.3% |
| 1999 Q1 | -57.72 Million EUR | -341.28% |
| 1999 Q2 | -60.01 Million EUR | -3.98% |
| 1999 Q3 | -58.11 Million EUR | 3.17% |
| 1999 Q4 | -72.65 Million EUR | -25.02% |
| 1999 FY | -247 Million EUR | -1616.66% |
| 1998 Q3 | 28.51 Million EUR | 146.52% |
| 1998 FY | 16.28 Million EUR | -80.14% |
| 1998 Q1 | 23.02 Million EUR | 44.9% |
| 1998 Q4 | 23.92 Million EUR | -16.09% |
| 1998 Q2 | -61.29 Million EUR | -366.18% |
| 1997 Q4 | 15.89 Million EUR | -5.77% |
| 1997 Q2 | 24.23 Million EUR | 2.97% |
| 1997 FY | 81.99 Million EUR | 0.0% |
| 1997 Q1 | 23.53 Million EUR | 0.0% |
| 1997 Q3 | 16.86 Million EUR | -30.41% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | -594 Million EUR | 184.006% |
| LIMES Schlosskliniken AG | 3.39 Million EUR | -14591.562% |
| M1 Kliniken AG | 10.27 Million EUR | -4756.757% |
| Maternus-Kliniken Aktiengesellschaft | -14.25 Million EUR | 3600.014% |
| MEDICLIN Aktiengesellschaft | -10.77 Million EUR | 4730.58% |
| RHÖN-KLINIKUM Aktiengesellschaft | 38.71 Million EUR | -1188.998% |
| VITA 34 AG | -1.86 Million EUR | 26855.871% |